Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer

PPAR Research

Volumn , Issue , 2012, Pages

  Pazienza, Valerio ^a   Tavano, Francesca ^a   Benegiamo, Giorgia ^a   Vinciguerra, Manlio ^b   Burbaci, Francesca Paola ^a   Copetti, Massimiliano ^a   Di Mola, Fabio Francesco ^a   Andriulli, Angelo ^a   Di Sebastiano, Pierluigi ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b INSTITUTE OF HEPATOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PERINEURIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84866151883     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/461784     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009. CA: Cancer Journal for Clinicians 2009 59 4 225 249 2-s2.0-67650874081 10.3322/caac.20006
2. Landis S. H., Murray T., Bolden S., Wingo P. A., Cancer Statistics, 1999. CA: Cancer Journal for Clinicians 1999 49 1 8 31 2-s2.0-0033006836 (Pubitemid 29094959)
3. Warshaw A. L., Fernández-del Castillo C., Pancreatic carcinoma. The New England Journal of Medicine 1992 326 7 455 465 10.1056/ NEJM199202133260706
4. Hariharan D., Saied A., Kocher H. M., Analysis of mortality rates for pancreatic cancer across the world. HPB 2008 10 1 58 62 2-s2.0-39749183343 10.1080/13651820701883148 (Pubitemid 351298114)
5. Ferré P., The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004 53 supplement 1 S43 S50 2-s2.0-0842263981 (Pubitemid 38168692)
6. Hsu M. H., Savas U., Griffin K. J., Johnson E. F., Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor α in HepG2 cells. Journal of Biological Chemistry 2001 276 30 27950 27958 2-s2.0-0035958960 10.1074/jbc.M100258200
7. Kliewer S. A., Forman B. M., Blumberg B., Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences of the United States of America 1994 91 7355 7359 10.1073/pnas.91.15.7355 (Pubitemid 24226862)
8. Farrow B., O'Connor K. L., Hashimoto K., Iwamura T., Evers B. M., Selective activation of PPAR γ inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. Surgery 2003 134 2 206 212 2-s2.0-0042829213 10.1067/msy.2003.221 (Pubitemid 37070340)
9. Cheng X., DNA modification by methyltransferases. Current Opinion in Structural Biology 1995 5 1 4 10 10.1016/0959-440X(95)80003-J
10. Smith S. S., Kaplan B. E., Sowers L. C., Newman E. M., Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation. Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4744 4748 2-s2.0-0026523796 10.1073/pnas.89.10.4744
11. Robert M. F., Morin S., Beaulieu N., Gauthier F., Chute I. C., Barsalou A., MacLeod A. R., DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nature Genetics 2003 33 1 61 65 2-s2.0-0037224722 10.1038/ng1068 (Pubitemid 36068683)
12. Rhee I., Bachman K. E., Park B. H., Jair K. W., Yen R. W. C., Schuebel K. E., Cui H., Feinberg A. P., Lengauer C., Kinzler K. W., Baylin S. B., Vogelstein B., DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002 416 6880 552 556 2-s2.0-18344390653 10.1038/416552a (Pubitemid 34288859)
13. American Joint Committee on Cancer, Edge S. B., Byrd D. R., Compton C. C., Exocrine and endocrine pancreas. AJCC Cancer Staging Manual 2010 7th New York, NY, USA Springer 241 246
14. Benegiamo G., Vinciguerra M., Mazzoccoli G., Piepoli A., Andriulli A., Pazienza V., DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes. Digestive Disease Science 2012 57 6 1598 1603 10.1007/s10620-012-2160-1
15. Lefebvre P., Chinetti G., Fruchart J. C., Staels B., Sorting out the roles of PPAR α in energy metabolism and vascular homeostasis. Journal of Clinical Investigation 2006 116 3 571 580 2-s2.0-33644652183 10.1172/JCI27989 (Pubitemid 43326861)
16. Tsujie M., Nakamori S., Okami J., Hayashi N., Hiraoka N., Nagano H., Dono K., Umeshita K., Sakon M., Monden M., Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor γ /retinoid X receptor α pathway. Experimental Cell Research 2003 289 1 143 151 2-s2.0-0043163884 10.1016/S0014-4827(03)00263-5 (Pubitemid 36993844)
17. Hashimoto K., Ethridge R. T., Evers B. M., Peroxisome proliferator-activated receptor γ ligand inhibits cell growth and invasion of human pancreatic cancer cells. International Journal of Gastrointestinal Cancer 2002 32 1 7 22 2-s2.0-0036934710 (Pubitemid 36323098)
18. Galli A., Ceni E., Crabb D. W., Mello T., Salzano R., Grappone C., Milani S., Surrenti E., Surrenti C., Casini A., Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPAR γ independent mechanisms. Gut 2004 53 11 1688 1697 2-s2.0-7244234089 10.1136/gut.2003.031997 (Pubitemid 39434116)
19. Motomura W., Nagamine M., Tanno S., Sawamukai M., Takahashi N., Kohgo Y., Okumura T., Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells. Journal of Gastroenterology 2004 39 5 461 468 2-s2.0-3042569217 10.1007/s00535-003-1324-3 (Pubitemid 38811730)
20. Koga H., Selvendiran K., Sivakumar R., Yoshida T., Torimura T., Ueno T., Sata M., PPAR γ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. International Journal of Oncology 2012 40 3 679 685 10.3892/ijo.2011.1237
21. Kristiansen G., Jacob J., Buckendahl A. C., Grützmann R., Alldinger I., Sipos B., Klöppel G., Bahra M., Langrehr J. M., Neuhaus P., Dietel M., Pilarsky C., Peroxisome proliferator-activated receptor γ is highly expressed in pancreatic cancer and is associated with shorter overall survival times. Clinical Cancer Research 2006 12 21 6444 6451 2-s2.0-33751303104 10.1158/1078-0432.CCR-06-0834 (Pubitemid 44799717)
22. Peng D. F., Kanai Y., Sawada M., Ushijima S., Hiraoka N., Kosuge T., Hirohashi S., Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Science 2005 96 7 403 408 2-s2.0-23844472366 10.1111/j.1349-7006.2005.00071.x (Pubitemid 41179741)
23. Deer E. L., González-Hernández J., Coursen J. D., Shea J. E., Ngatia J., Scaife C. L., Firpo M. A., Mulvihill S. J., Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010 39 4 425 435 2-s2.0-77951710240 10.1097/MPA.0b013e3181c15963
24. Hashimoto K., Farrow B. J., Evers B. M., Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell Line MIA PaCa-2. Pancreas 2004 28 2 153 159 2-s2.0-1442304433 10.1097/00006676- 200403000-00006 (Pubitemid 38269775)
25. Gaviraghi M., Tunici P., Valensin S., Rossi M., Giordano C., Magnoni L., Dandrea M., Montagna L., Ritelli R., Scarpa A., Bakker A., Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Bioscience Reports 2011 31 1 45 55 2-s2.0-79952236235 10.1042/BSR20100018